NIO752, Isotone Kochsalz-Lösung 0,9 % Braun Infusionslösung clinical trials

A Phase III, randomized, placebo-controlled, parallel group, double-blind study to evaluate the efficacy and safety of NIO752 in participants with Progressive Supranuclear Palsy followed by an Open Label Extension

This study is testing a new medicine, NIO752, for a condition called Progressive Supranuclear Palsy (PSP). It aims to see if the medicine can help people with PSP and if it's safe to use. Some people will get the medicine, and others a dummy treatment, to compare results.